Leptin for Obesity: Previous Failures, Promising Future.

Marcucci A, Mullally J, Frishman WH

Successful Treatment of Hypothalamic Obesity with Tirzepatide.

Brijmohan S, Mullally JA

Oral GLP-1 Receptor Agonists for Weight Loss.

Krinsky D, Marcucci A, Mullally JA, Frishman WH

The First Triple Agonist for Antiobesity: Retatrutide.

Tetelbaun L, Mullally JA, Frishman WH

Treatment of Bisphosphonate-Associated Atypical Femur Fracture With a Combination of Teriparatide and a Novel Surgical Technique.

Chincholi AH, Cooper AR, Mullally JA

Cagrilintide: A Long-Acting Amylin Analog for the Treatment of Obesity.

D'Ascanio AM, Mullally JA, Frishman WH

Tirzepatide for Weight Loss: Can Medical Therapy "Outweigh" Bariatric Surgery?

Novograd J, Mullally JA, Frishman WH

New-onset persistent hyperglycemia with initiation of brentuximab treatment.

Quintas J, Mowatt KB, Mullally JA, Steinberg A

A Case of Pituitary Apoplexy and Cavernous Sinus Syndrome during Hemodialysis.

Jamal Y, Camacho Y, Hanft S, Chiarolanzio P, Goldberg MD, Mullally JA

Thyrotoxicosis after COVID-19 Infection with a Delay in Graves' Disease Antibody Positivity.

Boyle DC, Mullally JA

Psychedelics for Medicinal Use: How Will This Alter the Collective Laboratory Consciousness?

Cotten SW, Strathmann FG, Barrett FS, Labay L, Mullally J, Sherwood AM, Wiegand F

Semaglutide for Weight Loss: Was It Worth the Weight?

Novograd J, Mullally J, Frishman WH

Weight-loss response to naltrexone/bupropion is modulated by the Taq1A genetic variant near DRD2 (rs1800497): A pilot study.

Mullally JA, Chung WK, LeDuc CA, Reid TJ, Febres G, Holleran S, Ramakrishnan R, Korner J

Sleeve Gastrectomy and Roux-en-Y Gastric Bypass Achieve Similar Early Improvements in Beta-cell Function in Obese Patients with Type 2 Diabetes.

Mullally JA, Febres GJ, Bessler M, Korner J

Complete Genome Sequence of Escherichia coli Phage APC_JM3.2 Isolated from a Chicken Cecum.

Mullally J, Stockdale SR, Smith MK, Draper LA, Ross PR, Hill C